Eli Lilly

AstraZeneca, Lilly, Sanofi and others raise prices to start July: report
AstraZeneca, Lilly, Sanofi and others raise prices to start July: report
Fierce Pharma
AstraZeneca
Eli Lilly
Sanofi
drug pricing
GSK
Biogen
Flag link:
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
Pharmaforum
artificial intelligence
machine learning
BenevolentAI
Eli Lilly
olumiant
COVID-19
Flag link:
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Beckers Hospital Review
Big Pharma
drug development
antibiotics
innovation
Eli Lilly
Pfizer
Merck
Boehringer Ingelheim
Bayer
CARB-X
Flag link:
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
migraines
physicians
Biohaven
Eli Lilly
AbbVie
Nurtec ODT
Ubrelvy
Reyvow
Flag link:
Third-quarter events to watch for large drug makers
Third-quarter events to watch for large drug makers
EP Vantage
Biogen
aducanumab
Sanofi
THOR-707
Bristol-Myers Squibb
pegbelfermin
Eli Lilly
FDA
Flag link:
Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?
Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?
Fierce Pharma
television ads
DTC ads
Merck
Eli Lilly
Amgen
drug pricing
Flag link:
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Fierce Pharma
Eli Lilly
migraines
Amgen
Teva Pharmaceutical
Lundbeck
Emgality
Flag link:
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Fierce Pharma
Novartis
Eli Lilly
Cosentyx
Taltz
spondyloarthritis
Flag link:
Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial
Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial
TheStreet.com
Eli Lilly
Verzenio
breast cancer
clinical trials
Flag link:
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
Forbes
Eli Lilly
COVID-19
pandemic
clinical trials
baricitinib
Flag link:
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
Fierce Pharma
ADA
diabetes
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Flag link:
Evox’s exosome platform draws Lilly in potential $1.2B CNS deal
Evox’s exosome platform draws Lilly in potential $1.2B CNS deal
BioWorld
Evox Therapeutics
Eli Lilly
exosomes
CNS
drug delivery
Flag link:
Lilly starts second COVID-19 antibody test with partner Junshi Biosciences, eyes combo trials
Lilly starts second COVID-19 antibody test with partner Junshi Biosciences, eyes combo trials
Fierce Biotech
Eli Lilly
Junshi Biosciences
COVID-19
antibodies
Flag link:
FDA approval tracker: several early decisions in May
FDA approval tracker: several early decisions in May
EP Vantage
FDA
Deciphera
Qinlock
Blueprint Medicines
Ayvakit
Eli Lilly
Retevmo
Bristol-Myers Squibb
Opdivo
Yervoy
Flag link:
Marketing Lilly's Cyramza, after split decision from FDA advisers, wins first-line lung cancer nod
Marketing Lilly's Cyramza, after split decision from FDA advisers, wins first-line lung cancer nod
Fierce Pharma
Eli Lilly
Cyramza
FDA
non-small cell lung cancer
Flag link:
Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis
Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis
Fierce Pharma
Eli Lilly
Taltz
Novartis
Cosentyx
axial spondyloarthritis
Flag link:
Eli Lilly begins first human tests of an antibody drug against Covid-19
Eli Lilly begins first human tests of an antibody drug against Covid-19
Stat
Eli Lilly
COVID-19
antibodies
pandemic
clinical trials
Flag link:
Lilly wins first-ever FDA approval for drug that can spot Alzheimer's 'tau tangles'
Lilly wins first-ever FDA approval for drug that can spot Alzheimer's 'tau tangles'
BioPharma Dive
Eli Lilly
FDA
Alzheimer's disease
R&D
tau tangles
Tauvid
imaging
diagnostics
Flag link:
The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round
The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round
Fierce Biotech
AbCellera
funding
COVID-19
Eli Lilly
Flag link:
A groundbreaking cancer drug nabs fast OK, giving Eli Lilly boasting rights as a rival speeds close behind
A groundbreaking cancer drug nabs fast OK, giving Eli Lilly boasting rights as a rival speeds close behind
Endpoints
Eli Lilly
selpercatinib
Retevmo
FDA
cancer
Loxo Oncology
Blueprint Medicines
Flag link:

Pages